Last night I did a stream outlining the work history of Andrew Pek, a long-time corporate consultant specializing in design thinking whose client base centered high-profile multinational pharmaceutical and financial firms. Pek was selected to become Chief Operating Officer for Children’s Health Defense (CHD) in February of 2023 according to an email sent out to supporters on April 6, 2023. Two months later Pek was not yet featured anywhere on the CHD website, and his LinkedIn profile had not been updated with his new employment status.
At the end of the stream a person commented in the chat that Pek was no longer with the organization. This came as a shock, since Michael Kane had just interviewed him last Friday, April 28 for Good Morning CHD TV. That short interview, which confirms Pek’s former position at Pfizer, is on Spotify, but not on the CHD TV page. Update: As of this morning, the interview has been removed from Spotify. Fortunately I recorded a key minutes of the audio, which you can listen to here.
Before putting together this presentation, I attempted repeatedly to confirm that the former Pfizer executive and pharmaceutical consultant was indeed the same man who had been hired to join the executive team at CHD. I got an initial reply last Thursday, that someone would check with Andrew and get back to me. I’d asked if he’d come to the organization from DxD Partners. No one ever replied to my follow-up texts.
If Pek is no longer with CHD, that would be an abrupt turn of events, since Kane had only done his “welcome our new COO” interview on Friday (interesting timing). In any event, I feel this information still has value, because it speaks to how the organization is being run. Note that the hire was made in February before Robert F. Kennedy Jr. and Mary Holland went on leave to run the campaign. Surely they were aware of his employment background. What led them to choose Pek above other candidates, if there were other candidates, is not known. If Pek is no longer an employee it’s worth asking what led to this unexpected change of heart? Robert F. Kennedy is now running for president of the United States. I think this episode speaks to his management approach and that of his executive staff.
I mean no ill will towards Mr. Pek. He seems like an accomplished consultant who clearly enjoys the work of flying around the world to rub elbows with c-suite executives, guiding them in unlocking their creative potential to expand the growth of their companies and generate handsome profits. Unfortunately, many of these firms are deeply embedded in the structure of Web3 human capital finance and precision medicine. This is the same structure that seeks to weave natural life into a gamified web of digital extended reality. Thus, as capable as he may be as a “consultant’s consultant” it is hard to imagine Pek was the best fit to steer CHD during a time of transition. Unless, perhaps his hire speaks to issues I continue to raise about social impact finance, “personalized” medicine (vaccinomics), innovative revenue streams for repurposed drugs, and managed wellness protocols related to chronic illness.
Last night someone in the comments replied in response to another comment noting how hard it was to find information on Mr. Pek and CHD, “…I hope when you Google him and CHD nothing comes up. That would be the best case scenario.” To which I replied, “Maybe the best case scenario is that we all better understand how CHD operates.” I’m sure people are busy scrubbing Mr. Pek out of the picture as we speak. The question is what led them to make that hire in the first place?
I’m pulling out a select group of screen shots that should pique your interest in watching the 1.25 hour long presentation. You can explore the material I presented by clicking your way through this diagram. Simply choose a circle, and a sidebar will open up with pertinent screen shots and links.
Explore the resources gathered here.
My text to confirm employment history of Mr. Pek. The interview happened within 24 hour of my inquiry.